Literature DB >> 7588857

Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA.

W A Craig1.   

Abstract

A variety of pharmacodynamic, pharmacokinetic and drug stability factors can influence the choice of drug, the dosing regimen and the method of drug administration for out-patient parenteral antibiotic therapy (OPAT). Beta-lactam antibiotics exhibit little if any concentration-dependent killing and produce short-term or no persistent effects with most bacterial pathogens. Optimal dosing regimens for these agents should provide serum levels that continually exceed the minimal inhibitory concentration (MIC) of the pathogen. Beta-lactam agents with long half-lives (greater than 2 hours) can provide these levels with intermittent dosing once or twice daily. Beta-lactam agents with shorter half-lives can be administered by programmable pumps or by continuous infusion providing the drug is sufficiently stable to degradation in solution. Imipenem and ampicillin are examples of drugs with short half-lives that are unstable in solution and must be dosed intermittently. Intramuscular administration slows absorption and can also prolong the length of time during which serum levels exceed the MIC of infecting bacteria. Aminoglycosides and fluoroquinolones, on the other hand, exhibit concentration-dependent killing and produce prolonged persistent effects. Optimal dosage regimens of these drugs should maximize serum levels. Once-daily dosing regimens for the aminoglycosides meet this goal and also appear to reduce drug-induced nephrotoxicity. Application of these principles to drug selection and administration in a hospital-based OPAT program has provided efficacious therapy and a low incidence of adverse reactions in an elderly population distributed over a wide geographic area.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588857     DOI: 10.1007/BF01690745

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Once-daily dosing decreases renal accumulation of gentamicin and netilmicin.

Authors:  G A Verpooten; R A Giuliano; L Verbist; G Eestermans; M E De Broe
Journal:  Clin Pharmacol Ther       Date:  1989-01       Impact factor: 6.875

2.  Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration.

Authors:  K A Neftel; M Wälti; H Spengler; A L de Weck
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

3.  Intramuscular ceftriaxone in home parenteral therapy.

Authors:  T A Russo; S Cook; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.

Authors:  J Blaser; B B Stone; M C Groner; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 5.  Killing and regrowth of bacteria in vitro: a review.

Authors:  W A Craig; S C Ebert
Journal:  Scand J Infect Dis Suppl       Date:  1990

6.  Clinical pharmacokinetics of continuous intravenous administration of penicillins.

Authors:  L G Visser; P Arnouts; R van Furth; H Mattie; P J van den Broek
Journal:  Clin Infect Dis       Date:  1993-09       Impact factor: 9.079

Review 7.  Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

Authors:  W A Craig
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

8.  Role for dual individualization with cefmenoxime.

Authors:  J J Schentag; I L Smith; D J Swanson; C DeAngelis; J E Fracasso; A Vari; J W Vance
Journal:  Am J Med       Date:  1984-12-21       Impact factor: 4.965

9.  Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man.

Authors:  M E De Broe; L Verbist; G A Verpooten
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

10.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Authors:  A Forrest; D E Nix; C H Ballow; T F Goss; M C Birmingham; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  10 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

Review 3.  Rational prescribing of antibacterials in hospitalised children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

Review 4.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Antimicrobial therapy for bacillus anthracis-induced polymicrobial infection in (60)Co gamma-irradiated mice.

Authors:  Thomas B Elliott; Itzhak Brook; Rita A Harding; S Samy Bouhaouala; Michael O Shoemaker; Gregory B Knudson
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 6.  Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.

Authors:  D Nathwani
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 7.  Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins.

Authors:  A D Tice
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 8.  Ambulatory use of parenteral antibacterials: contemporary perspectives.

Authors:  J E Leggett
Journal:  Drugs       Date:  2000       Impact factor: 9.546

9.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

Authors:  Goue Denis Gohore Bi; Jun Li; Fahima Nekka
Journal:  Theor Biol Med Model       Date:  2009-06-26       Impact factor: 2.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.